Analysts have been eager to weigh in on the Healthcare sector with new ratings on Chimerix (CMRX – Research Report) and Moderna (MRNA – Research Report). Chimerix (CMRX) In a report released today, Edward White from H.C. Wainwright reiterated a Buy rating on Chimerix, with a price target of $11.00. The company's shares closed last Thursday at $1.81, close to its 52-week low of $1.27. According to TipRanks.
https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-chimerix-cmrx-and-moderna-mrna?utm_source=advfn.com&utm_medium=referral
Moderna (NASDAQ:MRNA)
Historical Stock Chart
From Dec 2022 to Jan 2023 Click Here for more Moderna Charts.
Moderna (NASDAQ:MRNA)
Historical Stock Chart
From Jan 2022 to Jan 2023 Click Here for more Moderna Charts.